Physician profile
Brian E Barkley
NPI 1093158388
$1,243.59
in general payments reported to CMS, 2019-2025
13 companies · $37.68 in 2025
The $37.68 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $33.96 · 2021: $224 · 2022: $239 · 2023: $317 · 2024: $253 · 2025: $37.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $369.56 | 2022-2024 | Azstarys |
| Pfizer INC. | $251.21 | 2019-2025 | |
| Cranial Technologies, INC | $116.02 | 2019-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $92.37 | 2021-2022 | |
| Dynasplint Systems INC. | $86.09 | 2021 | |
| Glaxosmithkline, LLC. | $85.84 | 2023 | Bexsero, Menveo, Pediarix |
| Merck Sharp & Dohme LLC | $61.81 | 2021-2022 | |
| Tris Pharma INC | $60.18 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $55.62 | 2019-2023 | Jornay Pm |
| Alk-Abello, INC | $22.07 | 2023 | Ragwitek, Odactra, Grastek |
| Seqirus USA INC | $18.44 | 2025 | Flucelvax |
| Genentech USA, INC. | $12.53 | 2021 | |
| Mylan Pharmaceuticals INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Barkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.